MYGN Cash & Equivalents
Myriad Genetics Inc · Cash & Equivalents
MYGN Cash & Equivalents
Latest reported$149.60Mperiod ending
MYGN FY Cash & Equivalents ($13.20M → $149.60M)
Annual Cash & Equivalents
High-resolution chart · PNG
MYGN cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 149,600,000 | |
| 102,400,000 | |
| 132,100,000 | |
| 56,900,000 | |
| 257,400,000 | |
| 117,000,000 | |
| 163,700,000 | |
| 93,200,000 | |
| 110,900,000 | |
| 102,400,000 | |
| 68,500,000 | |
| 64,100,000 | |
| 64,800,000 | |
| 104,073,000 | |
| 86,352,000 | |
| 52,681,000 | |
| 92,840,000 | |
| 63,510,000 | |
| 237,734,000 | |
| 143,432,000 | |
| 98,573,000 | |
| 49,509,000 | |
| 83,983,000 | |
| 61,603,000 | |
| 61,066,953 | |
| 35,936,817 | |
| 56,214,736 | |
| 5,400,000 | |
| 14,600,000 | |
| 15,700,000 | |
| 13,200,000 |